Updates

Get Alerts
January 10, 2023 | PPP Updates
Dabrafenib in Combination with Trametinib Approved for Unresectable or Metastatic Tumors with BRAF V600E Mutation
Lauren Dietz, PharmD candidate, Jill M. Kolesar, PharmD, MS
January 10, 2023 | PPP Updates
Tralokinumab for the Management of Moderate-to-Severe Atopic Dermatitis
Celeste (Voight) VanAtta, PharmD, BCPS, Jenna Mills, PharmD, BCPS, Suzanne Surowiec, PharmD, BCACP
January 9, 2023 | PPP Updates
Short-course rifapentine-based regimen for the treatment of drug-susceptible pulmonary tuberculosis
Rachel Musgrove, PharmD, BCIDP
January 9, 2023 | PPP Updates
Updates in the Management of AmpC-producing Enterobacterales
Laysa Vasquez, PharmD, BCPS, Clinical Pharmacist, Megan Seddon, PharmD, BCIDP, Antimicrobial Stewardship Pharmacist
December 6, 2022 | PPP Updates
Inclisiran: A Newly Approved Cholesterol Lowering Medication
Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, Clinical Associate Professor
December 5, 2022 | PPP Updates
Management of Gram-Negative Bacteremia: Focus on the duration of treatment
Julia Kim, PharmD, Patrick Tu, PharmD, BCPS, AAHIVP
November 21, 2022 | PPP Updates
Daridorexant (Quviviq®): A Dual Orexin Receptor Antagonist for Adults with Insomnia
Jamie Kneebusch, PharmD, BCPS, BCPP
November 21, 2022 | PPP Updates
Futibatinib Approved for Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma
Lauren Dietz, PharmD candidate, Jill M. Kolesar, PharmD, MS
September 30, 2022 | PPP Updates
Approval of the Combination Nirmatrelvir/Ritonavir (Paxlovid™) for the Treatment of COVID-19 in the Outpatient Setting
Linda C Klumpp, MD1, Natalie Harris, PharmD Candidate 20232, Delvin Omer, PharmD Candidate 20232, P. Brandon Bookstaver, PharmD2
September 29, 2022 | PPP Updates
The Prevention and Management of Monkeypox Virus
Natalie Harris, PharmD Candidate 20231, Delvin Omer, PharmD Candidate 20231, P. Brandon Bookstaver, PharmD1
September 23, 2022 | PPP Updates
Supportive care for critically ill patients with COVID-19
Brianne Wolfe, PharmD, BCCCP, Kimberly Terry, PharmD, MS, BCCCP, BCPS, Linda Tyler, PharmD, FASHP
September 14, 2022 | PPP Updates
FDA Approval of Two Voquezna™ Products for Treatment of Helicobacter pylori Infection
Ryan Johnson, PharmD, BCPS, Assistant Professor, Pharmacy Practice, Cameron Javanmardi, PharmD, Assistant Professor, Pharmacy Practice, Ukamaka Diké Smith, PharmD, MBA, ACUE, Associate Professor, Pharmacy Practice
September 8, 2022 | PPP Updates
Newly Approved Azstarys® for Attention-Deficit/Hyperactivity Disorder (ADHD)
Morgan Carter, 4th Year PharmD Candidate, Amy Renaud, PharmD, TTS, Assistant Professor, Pharmacy Practice, Soheyla Mahdavian-Matthews, PharmD, BCGP, Professor, Pharmacy Practice
August 16, 2022 | PPP Updates
Albuterol–Budesonide Combination for Asthma Exacerbation
Nicole Cheung, PharmD, BCPS, Assistant Professor, Valerie Marcellus, PharmD, BCACP, Assistant Professor
August 1, 2022 | PPP Updates
Tezepelumab (Tezspire™) in Adolescents and Adults with Severe Asthma
Valerie Marcellus, PharmD, BCACP, Assistant Professor, Nicole Cheung, PharmD, BCPS, Assistant Professor
July 28, 2022 | PPP Updates
Global progress of COVID-19 vaccination
Lawrence Bean, PharmD PGY1 Pharmacy Resident, Jordan Jones, PharmD Candidate Class of 2023, P. Brandon Bookstaver, PharmD, FCCP, FIDSA
July 26, 2022 | PPP Updates
Lutetium Lu 177 vipivotide tetraxetan Approved for Metastatic Castration-Resistant Prostate Cancer
Lauren Dietz, PharmD candidate, Jill M. Kolesar, PharmD, MS
July 11, 2022 | PPP Updates
Challenges in Managing COVID-19 Vaccination in Solid Organ Transplant
Crystal L. Harrison, Pharm.D., BCGP; Medication Access Program (MAP) Pharmacist
June 20, 2022 | PPP Updates
Newly Approved and Updated Vaccines in 2021
Sarah Talley, PharmD, MPH, Melanie Rae Schrack, PharmD, Lacie McKamey, PharmD, BCPS, BCIDP
June 20, 2022 | PPP Updates
FDA Approves Wegovy (semaglutide) for Chronic Weight Management in Adults
Chelsa L. Deanes, Pharm.D., BCMAS, Clinical Pharmacist Fellow in Drug Information
May 23, 2022 | PPP Updates
Updates in the Recommendations for Pneumococcal Vaccination in Adults
Mary K. Vance, PharmD, PGY1 Pharmacy Practice Resident, Kayla R. Stover, PharmD, FCCP, FIDSA, BCIDP, BCPS, Associate Professor of Pharmacy Practice
May 23, 2022 | PPP Updates
Inclusion of Finerenone (Kerendia) in the 2022 American Diabetes Association Guidelines for Diabetes and Chronic Kidney Disease
Nicole Cheung, PharmD, BCPS; Assistant Professor, Pharmacy Practice, Cerris Chung, PharmD, BCACP; Collaborative Drug Therapy Management Pharmacist, Lauren Woody, PharmD Candidate 2022
May 9, 2022 | PPP Updates
Lybalvi® Use in Patients with Bipolar I Disorder and Schizophrenia
Alexander Vega, Fourth Year PharmD Candidate, Soheyla Mahdavian-Matthews, PharmD, BCGP, Professor, Pharmacy Practice, Amy Renaud, PharmD, TTS, Assistant Professor, Pharmacy Practice
May 9, 2022 | PPP Updates
Pediatric Growth Deficiency 2021 FDA Novel Drugs
Austin Mondloch, PharmD, Matthew Sherman, PharmD, MBA, Genevieve Lynn Ness, PharmD
May 6, 2022 | PPP Updates
Tezepelumab (Tezspire) in Adolescents and Adults with Severe Asthma
Valerie Marcellus, PharmD, BCACP, Assistant Professor, Pharmacy Practice, Nicole Cheung, PharmD, BCPS, Assistant Professor, Pharmacy Practice